MaviDx

MAVIDx, Inc. is an emerging company dedicated to developing innovative diagnostic platforms for unparalleled infectious disease detection. The company focuses on the discovery, development, and commercialization of diagnostic tests targeting coronaviruses, influenza viruses, and respiratory syncytial virus (RSV). Its platform is based on orthogonal implementation on the nCounter system. The platform offers multiplex testing and can provide a large-scale, straightforward workflow, verified accuracy, and significantly lower costs compared to current testing platforms.